ArcelorMittal SA vs Pfizer Inc — how do they compare? ArcelorMittal SA trades at $66.25 (market cap $50.01B), while Pfizer Inc trades at $24.92 (market cap $141.06B). The key difference: Pfizer Inc is far larger — about 2.8× ArcelorMittal SA's market cap, and Pfizer Inc pays the higher dividend (6.95%). Which is the better fit depends on your goals.
| MT | PFE | |
|---|---|---|
Market Cap | $50.01B | $141.06B |
Sector | Basic Materials | Health |
52-Week High | $71.65 | $28.56 |
52-Week Low | $30.39 | $23.29 |
Enterprise Value | $59.33B | $191.72B |
Dividend Yield | 0.91% | 6.95% |
Volume | — | 29,869,932 |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pfizer (PFE) trades at $25.05, down 0.36% on the day, with a bullish technical signal supported by strong quarterly earnings beats. The company maintains solid profitability with a 73.51% gross margin and 11.83% net income margin, though revenue has moderated post-pandemic. Recent news highlights pipeline advancements in oncology and obesity treatments, positioning PFE for potential growth catalysts in 2026.
The outlook for Pfizer is cautiously optimistic, with a consensus price target of $28.25 offering 13% upside. Key opportunities include dividend stability and pipeline innovation, while risks involve patent cliffs and competitive pressures. Analyst sentiment is mixed with 38% buy ratings, reflecting balanced views on recovery potential versus near-term challenges.
Trailing returns across standard periods
Latest headlines on both assets
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →